Company Abnova (Taiwan) Corporation. Taipei Exchange
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- TWD | - |
|
May. 09 | Abnova Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Abnova Corporation Announces Establishment of Risk Management Committee | CI |
Business Summary
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Monoclonal Antibody
31.7
%
| 133 | 32.2 % | 121 | 31.7 % | -8.85% |
Others
23.4
%
| 90 | 21.9 % | 89 | 23.4 % | -0.89% |
Paired Antibody
20.0
%
| 93 | 22.6 % | 77 | 20.0 % | -17.84% |
Protein
16.6
%
| 67 | 16.2 % | 63 | 16.6 % | -5.35% |
Polyclonal Antibodies
6.4
%
| 31 | 7.5 % | 25 | 6.4 % | -20.19% |
Testing Equipment
1.9
%
| -2 | -0.5 % | 7 | 1.9 % | -484.85% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Americas
50.4
%
| - | - | 193 | 50.4 % | - |
Europe
24.8
%
| - | - | 95 | 24.8 % | - |
Other Countries
21.5
%
| 53 | 12.9 % | 82 | 21.5 % | +54.94% |
Taiwan
3.2
%
| 29 | 7.1 % | 12 | 3.2 % | -57.76% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Pei Ju Jih
CEO | Chief Executive Officer | - | 18-06-30 |
Wilber Huang
CHM | Chairman | 58 | - |
I Ling Tung
IRC | Investor Relations Contact | - | - |
Ya Ping Chang
AUD | Comptroller/Controller/Auditor | - | - |
Shukuan Chen
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yueh Hung Chen
BRD | Director/Board Member | 60 | 20-06-18 |
Wilber Huang
CHM | Chairman | 58 | - |
Jia Hsie Lin
BRD | Director/Board Member | 73 | 17-06-22 |
Chi Ching Chiu
BRD | Director/Board Member | 53 | 21-12-13 |
Fang Wen Chen
BRD | Director/Board Member | 39 | 20-06-16 |
Shao De Ye
BRD | Director/Board Member | 57 | 17-06-22 |
Jin Jun Su
BRD | Director/Board Member | 55 | 17-06-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 60,554,000 | 45,828,594 ( 75.68 %) | 0 | 75.68 % |
Company contact information
![address Abnova (Taiwan) Corporation.](https://cdn.zonebourse.com/static/address/6830555.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+20.95% | 127B | |
+23.00% | 116B | |
+25.15% | 27.69B | |
-19.75% | 19.62B | |
-16.57% | 16.26B | |
-16.56% | 15.49B | |
+11.19% | 14.81B | |
-46.65% | 14.39B | |
+57.74% | 14.11B |
- Stock Market
- Equities
- 4133 Stock
- Stock
- Company Abnova (Taiwan) Corporation.